Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria (clinicaltrials.gov) - Mar 25, 2020 - P1; N=32; Not yet recruiting; Sponsor: United BioPharma; Initiation date: Jan 2020 ➔ May 2020; Trial primary completion date: Jun 2020 ➔ Nov 2020
Clinical • Trial initiation date • Trial primary completion date
|